Cargando…

Corrigendum to “Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice”

Detalles Bibliográficos
Autores principales:	Zhang, Jianwei, Yang, Zicong, Liang, Zhishan, Wang, Mengjie, Hu, Changxing, Chang, Chao, Shi, Lei, Ji, Qingwei, Liu, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076348/ https://www.ncbi.nlm.nih.gov/pubmed/35530977 http://dx.doi.org/10.1155/2022/9895309

Ejemplares similares

Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice
por: Zhang, Jianwei, et al.
Publicado: (2021)

Anti-Interleukin-16 Neutralizing Antibody Treatment Alleviates Sepsis-Induced Cardiac Injury and Dysfunction via the Nuclear Factor Erythroid-2 Related Factor 2 Pathway in Mice
por: Zhang, Jianwei, et al.
Publicado: (2021)

Corrigendum to “Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis”
por: Gao, Yunan, et al.
Publicado: (2017)

Corrigendum to “Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1β-Induced Inflammation and Apoptosis in Chondrocytes”
por: Qiu, Bo, et al.
Publicado: (2020)

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice
por: Ye, Jing, et al.
Publicado: (2017)

Corrigendum to “Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling”
por: Cheng, Xiaoli, et al.
Publicado: (2022)

Erratum to “Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice”
por: Ye, Jing, et al.
Publicado: (2018)

Corrigendum to: Infanticide vs. inherited cardiac arrhythmias
Publicado: (2023)

Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin [Corrigendum]
Publicado: (2021)

Corrigendum to “Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib”
por: Gorini, Stefania, et al.
Publicado: (2019)

Targeted Delivery Of Doxorubicin To HER2 Positive Tumor Models [Corrigendum]
Publicado: (2019)

Corrigendum to: Personalized teleprehabilitation in elective cardiac surgery: a study protocol of the Digital Cardiac Counselling randomized controlled trial
por: Scheenstra, Bart, et al.
Publicado: (2021)

Corrigendum to “Pregabalin Effect on Acute and Chronic Pain after Cardiac Surgery”
por: Bouzia, Aik, et al.
Publicado: (2018)

Cardiac resynchronization therapy pacemaker: critical appraisal of the adaptive CRT-P device [Corrigendum]
Publicado: (2016)

Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway [Corrigendum]
Publicado: (2017)

Corrigendum to “A Rare Presentation of Cardiac Tamponade from Metastatic Urothelial Carcinoma of the Bladder”
por: Palam, Sowmya, et al.
Publicado: (2019)

Corrigendum to: Enhancing efficiency in a cardiac investigations department by increasing remote patient monitoring
por: Ryan, Paul, et al.
Publicado: (2020)

Corrigendum to: Contemporary outcomes of cardiac surgery patients supported by the intra-aortic balloon pump
Publicado: (2022)

Antiresistin Neutralizing Antibody Alleviates Doxorubicin-Induced Cardiac Injury in Mice
por: Hu, Yewen, et al.
Publicado: (2022)

Patient satisfaction with cardiac rehabilitation: association with utilization, functional capacity, and heart-health behaviors [Corrigendum]
Publicado: (2017)

Corrigendum to DUSP-1 gene expression is not regulated by promoter methylation in diabetes-associated cardiac hypertrophy
Publicado: (2020)

[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth
por: Xuan, Zi-Xue, et al.
Publicado: (2023)

Corrigendum to “Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch” [Redox Biol. 52 (2022) 1–16/102311]
por: Ding, Mingge, et al.
Publicado: (2022)

Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288]
por: Cai, Chen, et al.
Publicado: (2023)

Corrigendum to “Role of Interleukin-18 in Modulation of Oral Carcinoma Cell Proliferation”
por: Inflammation, Mediators of
Publicado: (2018)

Corrigendum to “Metabolic Syndrome, Inflammation, and Cancer”
por: Wu, Yong, et al.
Publicado: (2017)

MicroRNA-144 attenuates cardiac ischemia/reperfusion injury by targeting FOXO1
por: E, Lusha, et al.
Publicado: (2020)

Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum]
Publicado: (2022)

Corrigendum to “Adipose-Derived Stromal Cells Attenuate Adipose Inflammation in Obesity through Adipocyte Browning and Polarization of M2 Macrophages”
por: Zhang, Wen-Chao, et al.
Publicado: (2022)

Corrigendum to ‘A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19’
por: McElvaney, Oliver J, et al.
Publicado: (2020)

Corrigendum: IRB Approval Number Correction. Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism
por: Lim, Jung Soo, et al.
Publicado: (2020)

Corrigendum to: Risk factors associated with inpatient cardiac arrest during emergency endotracheal intubation at general wards
por: Park, Chul
Publicado: (2020)

Corrigendum to: Cardiac tamponade and constrictive pericarditis due to Actinomyces meyeri bacterial pericarditis: a case report
Publicado: (2022)

Corrigendum to: A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma
por: Butt, Omar H, et al.
Publicado: (2022)

Corrigendum to: Controversies in cardiac surgery: do multivessel arterial revascularization and beating heart bypass operations improve prognosis?
Publicado: (2019)

Corrigendum to “Prenatal Diagnosis of Cardiac Diverticulum with Pericardial Effusion in the First Trimester of Pregnancy with Resolution after Early Pericardiocentesis”
por: Garcia Rodriguez, Raquel, et al.
Publicado: (2017)

CORRIGENDUM: Utility of (99 m)Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice
por: Tsutsui, Yoshitomo, et al.
Publicado: (2019)

Corrigendum to Solanine Attenuated Hepatocarcinoma Migration and Invasion Induced by Acetylcholine
Publicado: (2022)

Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice
por: Ye, Jing, et al.
Publicado: (2020)

Corrigendum: Primary Purulent Pericarditis with Cardiac Tamponade due to Oropharyngeal Polymicrobial Infection: A Case Report and Literature Review
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mdua8bjvhag9ejtcnamfcvlgrk